The company has developed unique technology for administering certain drugs subcutaneously at home, rather than through IV in a clinic. The uptake of this is receiving an impulse as Grifols, a big name in IV, is shifting towards SC and the pandemic underlines the advantage of at home administration. More PIDD and CIDP drugs are […]
Entries Tagged as 'KRMD'
June 13th, 2020 · Comments Off on KORU Is Getting Tailwind From A Shift Away From IV And The Pandemic
January 29th, 2020 · Comments Off on KORU Medical Systems Growth Is Set To Continue
The company is enjoying multiple growth vectors pushing the shares higher as its home infusion solutions are a major cost saver for the healthcare system. It also sprouts an attractive razor and blade business model. However, we see little reason for further valuation multiple expansion as the shares seem fairly fully valued. Source: KORU Medical […]